FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799993454> ?p ?o ?g. }

• W2799993454 abstract "Smoking rates are higher in New Zealand (NZ) adults with mental illnesses and alcohol and other drug (AOD) addictions, compared to the overall population. Quit attempts using “gold standard” smoking cessation treatments often fail in people with these conditions, so more flexible treatment regimens that adapt to a person’s responsiveness to treatment are worth investigating. The STATUS trial aims to evaluate the effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation among varenicline non-responders in treatment for mental health illnesses and/or AOD addictions. This is a pragmatic two-arm, open-label, randomised trial. Participants will be daily smokers using mental health and/or addiction services in Auckland, aged ≥18 years, motivated to quit smoking, and eligible to access varenicline through the NZ special authority process. After 2 weeks of using varenicline plus behavioural support, participants who have not reduced their daily smoking by ≥50% will be randomised (1:1) to either 10 weeks of continued varenicline use or 10 weeks of varenicline plus an 18 mg/mL nicotine e-cigarette. All participants will receive weekly withdrawal-orientated behavioural support calls for 6 weeks post-randomisation. The primary outcome is self-reported biochemically-verified (exhaled carbon monoxide) continuous abstinence at 24 weeks post-randomisation. Secondary outcomes, measured at six, 12 and 24 weeks post-randomisation include: self-reported continuous abstinence, 7-day point prevalence abstinence, smoking reduction, time to relapse, cross-over, use of other smoking cessation support, serious adverse events, treatment adherence, compliance, acceptability, dual use, continuation of treatment use, mental illness symptoms and AOD use, health-related quality of life, and cost-analysis. A sample size of 338 will confer 80% power (p = 0.05) to detect a 15% absolute difference between the varenicline alone and varenicline plus e-cigarette groups. People with mental illness and/or AOD addictions are just as motivated as others to quit smoking, but are less likely to succeed. Adapting smoking cessation medication after a lack of responsiveness in the first 2 weeks of initial treatment in this priority population by adding a nicotine e-cigarette may be one way to increase long-term quit rates. Australian NZ Clinical Trial Registry: ACTRN12616001355460 (29 September 2016)." @default.
• W2799993454 created "2018-05-17" @default.
• W2799993454 creator A5018521664 @default.
• W2799993454 creator A5048787921 @default.
• W2799993454 creator A5053455632 @default.
• W2799993454 creator A5077696477 @default.
• W2799993454 creator A5077864128 @default.
• W2799993454 creator A5080147923 @default.
• W2799993454 creator A5080398922 @default.
• W2799993454 creator A5083271536 @default.
• W2799993454 date "2018-05-04" @default.
• W2799993454 modified "2023-10-11" @default.
• W2799993454 title "The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial" @default.
• W2799993454 cites W1557379673 @default.
• W2799993454 cites W1702723615 @default.
• W2799993454 cites W1907559804 @default.
• W2799993454 cites W1931781407 @default.
• W2799993454 cites W1964625218 @default.
• W2799993454 cites W1976653331 @default.
• W2799993454 cites W1978524840 @default.
• W2799993454 cites W1986773132 @default.
• W2799993454 cites W1993729509 @default.
• W2799993454 cites W2020217373 @default.
• W2799993454 cites W2021054271 @default.
• W2799993454 cites W2028087632 @default.
• W2799993454 cites W2033726919 @default.
• W2799993454 cites W2045213593 @default.
• W2799993454 cites W2051618313 @default.
• W2799993454 cites W2053183266 @default.
• W2799993454 cites W2074854406 @default.
• W2799993454 cites W2080075236 @default.
• W2799993454 cites W2084289344 @default.
• W2799993454 cites W2089345569 @default.
• W2799993454 cites W2093274439 @default.
• W2799993454 cites W2100333721 @default.
• W2799993454 cites W2101931786 @default.
• W2799993454 cites W2108782374 @default.
• W2799993454 cites W2112525126 @default.
• W2799993454 cites W2118061336 @default.
• W2799993454 cites W2121853742 @default.
• W2799993454 cites W2122799794 @default.
• W2799993454 cites W2124679681 @default.
• W2799993454 cites W2128399010 @default.
• W2799993454 cites W2135504811 @default.
• W2799993454 cites W2138550845 @default.
• W2799993454 cites W2140516020 @default.
• W2799993454 cites W2141348739 @default.
• W2799993454 cites W2141831357 @default.
• W2799993454 cites W2145829640 @default.
• W2799993454 cites W2158598656 @default.
• W2799993454 cites W2162097818 @default.
• W2799993454 cites W2163084572 @default.
• W2799993454 cites W2163364964 @default.
• W2799993454 cites W2340896985 @default.
• W2799993454 cites W2520915513 @default.
• W2799993454 cites W2587708060 @default.
• W2799993454 cites W2747717603 @default.
• W2799993454 doi "https://doi.org/10.1186/s12889-018-5351-7" @default.
• W2799993454 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5935940" @default.
• W2799993454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29728074" @default.
• W2799993454 hasPublicationYear "2018" @default.
• W2799993454 type Work @default.
• W2799993454 sameAs 2799993454 @default.
• W2799993454 citedByCount "15" @default.
• W2799993454 countsByYear W27999934542018 @default.
• W2799993454 countsByYear W27999934542020 @default.
• W2799993454 countsByYear W27999934542021 @default.
• W2799993454 countsByYear W27999934542022 @default.
• W2799993454 countsByYear W27999934542023 @default.
• W2799993454 crossrefType "journal-article" @default.
• W2799993454 hasAuthorship W2799993454A5018521664 @default.
• W2799993454 hasAuthorship W2799993454A5048787921 @default.
• W2799993454 hasAuthorship W2799993454A5053455632 @default.
• W2799993454 hasAuthorship W2799993454A5077696477 @default.
• W2799993454 hasAuthorship W2799993454A5077864128 @default.
• W2799993454 hasAuthorship W2799993454A5080147923 @default.
• W2799993454 hasAuthorship W2799993454A5080398922 @default.
• W2799993454 hasAuthorship W2799993454A5083271536 @default.
• W2799993454 hasBestOaLocation W27999934541 @default.
• W2799993454 hasConcept C118552586 @default.
• W2799993454 hasConcept C126322002 @default.
• W2799993454 hasConcept C134362201 @default.
• W2799993454 hasConcept C142724271 @default.
• W2799993454 hasConcept C168563851 @default.
• W2799993454 hasConcept C2777053506 @default.
• W2799993454 hasConcept C2777843972 @default.
• W2799993454 hasConcept C2779547902 @default.
• W2799993454 hasConcept C2780478649 @default.
• W2799993454 hasConcept C2780687700 @default.
• W2799993454 hasConcept C2908647359 @default.
• W2799993454 hasConcept C48856860 @default.
• W2799993454 hasConcept C71924100 @default.
• W2799993454 hasConcept C99454951 @default.
• W2799993454 hasConceptScore W2799993454C118552586 @default.
• W2799993454 hasConceptScore W2799993454C126322002 @default.
• W2799993454 hasConceptScore W2799993454C134362201 @default.
• W2799993454 hasConceptScore W2799993454C142724271 @default.
• W2799993454 hasConceptScore W2799993454C168563851 @default.
• W2799993454 hasConceptScore W2799993454C2777053506 @default.
• W2799993454 hasConceptScore W2799993454C2777843972 @default.

• next